Last Close
Apr 09  •  01:06PM ET
0.7497
Dollar change
-0.0012
Percentage change
-0.16
%
Index
-
P/E
-
EPS (ttm)
-5.42
Insider Own
5.88%
Shs Outstand
10.53M
Perf Week
4.97%
Market Cap
7.90M
Forward P/E
-
EPS next Y
-1.75
Insider Trans
0.00%
Shs Float
9.91M
Perf Month
-9.07%
Enterprise Value
13.81M
PEG
-
EPS next Q
-0.54
Inst Own
13.95%
Perf Quarter
-9.57%
Income
-31.00M
P/S
1.14
EPS this Y
72.16%
Inst Trans
-1.13%
Perf Half Y
-69.27%
Sales
6.92M
P/B
0.78
EPS next Y
54.47%
ROA
-87.43%
Perf YTD
3.26%
Book/sh
0.97
P/C
0.44
EPS next 5Y
51.60%
ROE
-240.75%
52W High
5.84 -87.17%
Perf Year
-84.38%
Cash/sh
1.69
P/FCF
-
EPS past 3/5Y
25.75% 17.29%
ROIC
-99.00%
52W Low
0.65 15.16%
Perf 3Y
-99.44%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
- 21.66%
Gross Margin
1.83%
Volatility
9.29% 7.63%
Perf 5Y
-99.37%
Dividend TTM
-
EV/Sales
2.00
EPS Y/Y TTM
74.30%
Oper. Margin
-419.51%
ATR (14)
0.07
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
4.77
Sales Y/Y TTM
129.04%
Profit Margin
-447.75%
RSI (14)
43.22
Dividend Gr. 3/5Y
- -
Current Ratio
5.12
EPS Q/Q
71.23%
SMA20
-0.41%
Beta
0.51
Payout
-
Debt/Eq
2.91
Sales Q/Q
104.66%
SMA50
-17.65%
Rel Volume
0.02
Prev Close
0.75
Employees
61
LT Debt/Eq
2.86
SMA200
-59.28%
Avg Volume
7.55M
Price
0.75
IPO
Sep 23, 2016
Option/Short
No / Yes
Trades
Volume
69,419
Change
-0.16%
Date Action Analyst Rating Change Price Target Change
Jul-17-25Initiated D. Boral Capital Buy $11
Jun-25-24Downgrade BTIG Research Buy → Neutral
Jul-28-23Initiated Piper Sandler Overweight $10
Jun-15-23Initiated BTIG Research Buy $15
Apr-28-21Initiated Truist Buy $12
Oct-22-19Initiated Oppenheimer Outperform $9
Apr-01-26 09:00AM
Mar-26-26 04:05PM
Mar-17-26 04:35PM
Mar-11-26 07:00AM
Mar-10-26 07:30AM
05:39AM Loading…
Mar-04-26 05:39AM
Feb-20-26 08:00PM
08:00AM
Feb-13-26 04:32PM
07:30AM
Feb-04-26 08:00AM
Jan-27-26 04:05PM
Jan-26-26 04:05PM
Jan-14-26 08:30AM
Jan-13-26 01:40PM
07:30AM Loading…
07:30AM
Dec-30-25 07:30AM
Dec-17-25 07:30AM
Nov-26-25 04:30PM
Nov-11-25 12:02AM
Nov-10-25 04:05PM
Nov-05-25 08:00AM
Oct-23-25 08:00AM
Sep-22-25 08:00AM
Sep-08-25 03:55PM
08:00AM
Sep-03-25 08:00AM
Aug-20-25 08:00AM
Aug-13-25 03:11AM
Aug-12-25 05:35PM
04:05PM Loading…
04:05PM
Aug-11-25 09:45AM
Aug-07-25 06:20PM
Jul-25-25 08:00AM
Jul-22-25 07:30AM
Jun-26-25 09:55AM
Jun-18-25 03:01AM
Jun-17-25 05:15PM
04:01PM
Jun-16-25 09:16AM
08:00AM
May-29-25 08:15AM
May-28-25 05:20PM
May-20-25 08:00AM
Apr-24-25 04:05PM
Apr-21-25 04:05PM
Apr-15-25 04:05PM
Apr-09-25 04:05PM
Apr-01-25 08:00AM
Mar-31-25 08:00AM
Mar-24-25 04:05PM
Mar-23-25 08:38AM
Mar-11-25 07:30AM
Mar-06-25 04:05PM
Feb-10-25 04:05PM
Feb-07-25 07:10AM
Feb-05-25 09:29AM
Jan-27-25 04:05PM
Jan-24-25 09:15AM
Jan-06-25 08:00AM
Dec-03-24 04:05PM
Dec-02-24 07:30AM
Nov-26-24 07:30AM
Nov-14-24 04:05PM
Nov-11-24 04:05PM
07:00AM
Nov-08-24 07:06AM
Oct-29-24 04:22PM
Oct-07-24 07:00AM
Oct-02-24 07:30AM
Sep-28-24 07:40AM
07:35AM
Sep-27-24 07:34AM
07:32AM
07:30AM
Sep-23-24 08:00AM
Aug-06-24 04:05PM
Jul-31-24 04:15PM
Jul-23-24 04:05PM
Jul-16-24 04:05PM
Jul-10-24 09:55AM
Jun-26-24 08:01AM
Jun-25-24 10:31AM
08:28AM
07:37AM
Jun-24-24 08:53PM
05:25PM
04:15PM
Jun-13-24 04:05PM
Jun-03-24 07:00AM
May-23-24 04:09PM
May-01-24 07:00AM
Mar-21-24 12:00PM
Mar-20-24 09:00AM
Feb-13-24 08:51AM
Feb-12-24 04:05PM
Jan-18-24 08:00AM
Dec-27-23 07:30AM
Dec-21-23 01:40AM
Nov-15-23 04:05PM
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lisi Steven A.CEO and Chairman of the BoardJul 21 '25Buy3.256,00019,4913,327,411Jul 23 04:05 PM